Literature DB >> 22248910

Effects of proton pump inhibitors on pediatric inflammatory esophagogastric polyps.

Kyong Eun Choi1, Mi Jin Kim, Ji Hyuk Lee, Jong Seung Lee, Jee Hyun Lee, Yon Ho Choe.   

Abstract

BACKGROUND: The aim of this study was to investigate the effects of proton pump inhibitors on symptomatic inflammatory esophagogastric polyps (IEPs) in a pediatric cohort and to determine the optimal duration of treatment.
METHODS: The 11 patients with IEPs were managed with lansoprazole. Follow-up endoscopies were performed at 2 and 6 months after the start of medication. Medication was discontinued when the clinical symptoms completely resolved and the polyp size was reduced by more than 50% compared to the initial size.
RESULTS: The initial polyp size was 13.7 ± 3.3 mm. After 2 months of medication, the polyp size was reduced to 8.0 ± 5.8 mm. At 6 months, the polyp size was 4.7 ± 2.2 mm. The mean duration of medication was 4.8 ± 2.1 months. The duration of medication and the change in the polyp size appeared to have a linear correlation (p < 0.001). According to the formula used to calculate polyp size, the optimal duration of treatment was more than 7 months for complete resolution of the polyps.
CONCLUSIONS: Proton pump inhibitor was effective for the treatment of IEPs. About 5 months of lansoprazole was adequate to treat IEPs in children. The optimal duration for complete resolution of the polyp might be more than 7 months.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22248910     DOI: 10.1159/000327909

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  1 in total

1.  Complete Resolution of Pseudomalignant Erosion in a Reflux Gastroesophageal Polyp with Proton Pump Inhibitor.

Authors:  Takahiko Nakajima; Haruo Yagi; Hayato Baba; Takashi Minamisaka; Shigeharu Miwa; Shinichi Hayashi; Takeshi Nishida; Hideki Hatta; Koichi Tsuneyama; Johji Imura
Journal:  Case Rep Pathol       Date:  2015-11-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.